Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1952 1
1953 3
1954 3
1955 1
1956 2
1957 1
1959 1
1961 2
1962 6
1963 4
1964 11
1965 9
1966 10
1967 2
1968 8
1969 12
1970 9
1971 15
1972 12
1973 10
1974 39
1975 40
1976 41
1977 33
1978 29
1979 37
1980 38
1981 34
1982 39
1983 61
1984 56
1985 54
1986 48
1987 53
1988 64
1989 90
1990 107
1991 110
1992 223
1993 323
1994 451
1995 510
1996 607
1997 664
1998 677
1999 697
2000 704
2001 696
2002 715
2003 772
2004 762
2005 836
2006 907
2007 854
2008 808
2009 806
2010 836
2011 906
2012 1003
2013 936
2014 959
2015 968
2016 966
2017 931
2018 1013
2019 1025
2020 1083
2021 1002
2022 886
2023 822
2024 985
2025 1266
2026 798

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26,776 results

Results by year

Filters applied: . Clear all
Page 1
Drug name recognition in biomedical texts: a machine-learning-based method.
He L, Yang Z, Lin H, Li Y. He L, et al. Drug Discov Today. 2014 May;19(5):610-7. doi: 10.1016/j.drudis.2013.10.006. Epub 2013 Oct 16. Drug Discov Today. 2014. PMID: 24140287 Review.
Currently, there is an urgent need to develop a technology for extracting drug information automatically from biomedical texts, and drug name recognition is an essential prerequisite for extracting drug information. This article presents a machine-lear …
Currently, there is an urgent need to develop a technology for extracting drug information automatically from biomedical texts, and …
What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications.
Serafini M, Cargnin S, Massarotti A, Tron GC, Pirali T, Genazzani AA. Serafini M, et al. J Med Chem. 2021 Apr 22;64(8):4410-4429. doi: 10.1021/acs.jmedchem.1c00181. Epub 2021 Apr 13. J Med Chem. 2021. PMID: 33847110 Free PMC article. Review.
The World Health Organization assigns international nonproprietary names (INN), also known as common names, to compounds upon request from drug developers. Structures of INNs are publicly available and represent a source, albeit underused, to understand trend …
The World Health Organization assigns international nonproprietary names (INN), also known as common names, to compounds upon …
Effects of Text Enhancement on Reduction of Look-Alike Drug Name Confusion: A Systematic Review and Meta-analysis.
Wang H, Tao D, Yan M. Wang H, et al. Qual Manag Health Care. 2021 Oct-Dec 01;30(4):233-243. doi: 10.1097/QMH.0000000000000303. Qual Manag Health Care. 2021. PMID: 34326288
BACKGROUND AND OBJECTIVES: Drug name confusion induced by look-alike drug names represents a serious health care management problem in practice. Text enhancement by changing visual attributes of look-alike drug names has been proposed and …
BACKGROUND AND OBJECTIVES: Drug name confusion induced by look-alike drug names represents a serious health care …
Pharmacokinetic Enhancers.
[No authors listed] [No authors listed] 2017 Aug 17. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Aug 17. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643249 Free Books & Documents. Review.
Pharmacokinetic enhancers or boosting agents are used in combination with a primary therapeutic agent, not for their direct effects on the disease or condition for which they are used, but because they enhance the activity, increase drug levels and/or prolong the half-life …
Pharmacokinetic enhancers or boosting agents are used in combination with a primary therapeutic agent, not for their direct effects on the d …
RxNorm for drug name normalization: a case study of prescription opioids in the FDA adverse events reporting system.
Le H, Chen R, Harris S, Fang H, Lyn-Cook B, Hong H, Ge W, Rogers P, Tong W, Zou W. Le H, et al. Front Bioinform. 2024 Jan 5;3:1328613. doi: 10.3389/fbinf.2023.1328613. eCollection 2023. Front Bioinform. 2024. PMID: 38250436 Free PMC article.
Studies using FAERS and other spontaneous reporting AEs database without drug name normalization may encounter incomplete collection of AE reports from non-standard drug names and the accuracies of the results might be impacted. ...Our method of using …
Studies using FAERS and other spontaneous reporting AEs database without drug name normalization may encounter incomplete coll …
Drug name integrity.
WOODS WE. WOODS WE. Hosp Manage. 1961 Jan;91:18-21. Hosp Manage. 1961. PMID: 13786588 No abstract available.
Psycholinguistic tests predict real-world drug name confusion error rates: a cross-sectional experimental study.
Lambert BL, Schroeder SR, Galanter WL, Schiff GD, Vaida AJ, Gaunt MJ, Opfermann MB, Rash Foanio C, Falck S, Mirea N. Lambert BL, et al. BMJ Qual Saf. 2025 Oct 17;34(11):729-736. doi: 10.1136/bmjqs-2024-017688. BMJ Qual Saf. 2025. PMID: 40037800
BACKGROUND: Wrong-drug medication errors are common. Regulators screen drug names for confusability, but screening methods lack empirical validation. ...METHODS: Nineteen pharmacists and 18 pharmacy technicians completed memory and perception tests assessing …
BACKGROUND: Wrong-drug medication errors are common. Regulators screen drug names for confusability, but screening meth …
Generically speaking.
[No authors listed] [No authors listed] Drug Ther Bull. 2009 Oct;47(10):109. doi: 10.1136/dtb.2009.09.0039. Drug Ther Bull. 2009. PMID: 19809083
It's best to use the generic name when referring to a medicine. This reduces the likelihood of accidental double prescribing or purchase of a drug, particularly if it has more than one brand name. ...Nevertheless, brand names enjoy undue prominence, ev …
It's best to use the generic name when referring to a medicine. This reduces the likelihood of accidental double prescribing or purch …
26,776 results
You have reached the last available page of results. Please see the User Guide for more information.